The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice

Journal of the American Academy of Dermatology

Volumn 40, Issue 6 I, 1999, Pages 925-929

  Arbiser, J L ^a   Panigrathy, D ^a   Klauber, N ^a   Rupnick, M ^a   Flynn, E ^a   Udagawa, T ^a   D'Amato, R J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; HEMANGIOENDOTHELIOMA; INOCULATION; MALE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

EID: 0032997411     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70080-0     Document Type: Article

References (19)

1. JB Mulliken J. Glowacki Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics Plast Reconstr Surg 69 1982 412 420
2. WH Morrison RM Byers AS Garden HL Evans KK Ang LJ. Peters Cutaneous angiosarcoma of the head and neck: a therapeutic dilemma Cancer 76 1995 319 327
3. T Boehm J Folkman T Brooder MS. O’Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
4. D Ingber T Fujita S Kishimoto K Sudo T Kanamaru H Brem Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth Nature 348 1990 555 557
5. RJ D’Amato CM Lin E Flynn J Folkman E. Hamel 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site Proc Natl Acad Sci U S A 91 1994 3964 3968
6. T Fotsis Y Zhang M Pepper H Adlercreutz R Montesano PP Nawroth The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth Nature 368 1994 237 239
7. JL Arbiser MA Moses CA Fernandez N Ghiso Y Cao N Klauber Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways Proc Natl Acad Sci U S A 94 1997 861 866
8. R Goldman Z. Bar-Shavit Dual effect of normal and stimulated macrophages and their conditioned media on target cell proliferation J Natl Cancer Inst 63 1979 1009 1016
9. J Kurebayashi SW McLeskey MD Johnson ME Lippman RB Dickson FG. Kern Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and lac Z Cancer Res 53 1993 2178 2187
10. O Enjolras MC Riche JJ Merland JP. Escande Management of alarming hemangiomas in infancy: a review of 25 cases Pediatrics 85 1990 491 498
11. RA Ezekowitz JB Mulliken J. Folkman Interferon alpha 2A therapy for life threatening hemangiomas in infancy N Engl J Med 326 1992 1456 1463
12. F Blei SJ Orlow R. Geronemus Multimodal management of diffuse neonatal hemangiomatosis J Am Acad Dermatol 34 1996 337 342
13. LR Zukerberg BJ Nickoloff SW. Weiss Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis Am J Surg Pathol 17 1993 321 328
14. WY Tsang JK. Chan Kaposi-like infantile hemangioendothelioma: a distinctive vascular neoplasm of the retroperitoneum Am J Surg Pathol 15 1991 982 989
15. K Vin-Christian TH McCalmont IJ. Frieden Kaposiform hemangioendothelioma: an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy Arch Dermatol 133 1997 1573 1578
16. N Sin L Meng MQ Wang JJ Wen WG Bornmann CM. Crews The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2 Proc Natl Acad Sci U S A 94 1997 6099 6103
17. BJ Dezube JH Von Roenn J Holden-Wiltse TW Cheung SC Remick TP Cooley Fumagillin analog in the treatment of Kaposi’s sarcoma: a phase I AIDS clinical trial group study J Clin Oncol 16 1998 1444 1449
18. MS O’Reilly L Holmgren Y Shing RA Rosenthal M Moses WS Lane Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
19. BJ Lannutti ST Gately ME Quevedo GA Soff AS. Paller Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo Cancer Res 57 1997 5277 5280